Last update Nov. 3, 2018
Very Low Risk
Chlamydia trachomatis infection is a common sexually transmitted infection.
Pregnant women with untreated active infection can infect the newborn during delivery and cause eye infections and pneumonia.
Transmission through breastmilk has not been demonstrated.
Antibodies against chlamydia are present in breastmilk, which could protect the infant (Lawrence 2016, Lampe 1998, Ramsey 1998, Skaug 1982).
It is not necessary to interrupt breastfeeding or separate the infant from the mother if the mother is diagnosed with chlamydia (Lawrence 2016, OWH 2015).
The treatments for the disease (azithromycin, doxycycline, erythromycin, levofloxacin, ofloxacin) are compatible with breastfeeding.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM